HIGHLIGHTS
- who: Implantable Bioresponsive Hydrogel and collaborators from the Department of Tumor Radiotherapy, Air Force Medical Center, PLA, Beijing, China, Department of Stomatology, The First Medical Center, Chinese PLA General Hospital, Beijing, China, College of Chemical Engineering, Beijing University of Chemical have published the research: Implantable Bioresponsive Hydrogel Prevents Local Recurrence of Breast Cancer by Enhancing Radiosensitivity, in the Journal: (JOURNAL)
- what: The authors attempted to load nano-su with this carrier.
- how: Showed that the combination treatment group significantly inhibited approximately 75% of the migration efficacy compared with the control. Indicated that comparing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.